The Safety and Effects of the Beta-Blocker, Nadolol, in Mild Asthma; An Open-label Pilot Study

Beta-blockers are currently contraindicated in asthma because their acute administration may be associated with worsening bronchospasm. However, their effects and safety with their chronic administration are not well evaluated. The rationale for this pilot study was based on the paradigm shift that...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Hanania, Nicola A, Singh, Supria, Eli-Wali, Rami, Flashner, Michael, Franklin, Amie E, Garner, William J, Dickey, Burton F, Parra, Sergio, Ruoss, Stephen J, Shardonofsky, Felix, O'Connor, Brian J, Page, Clive, Bond, Richard A
Формат: Artigo
Язык:Inglês
Опубликовано: 2007
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2254137/
https://ncbi.nlm.nih.gov/pubmed/17703976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pupt.2007.07.002
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы